In September 2025, Growthink Capital Research tracked $11.02 billion in venture funding, surging from $7.61 billion in August.
The month’s biggest funding event belonged to Figure ($1 billion), a humanoid robot designed to address drastic labor shortages and reduce the number of workers in unsafe jobs, enabling businesses to deploy and automate manual labor.
This month there were 32 companies that reported raising over $100M, while last month, there were only 24 (a 33% increase from August). Aside from Figure, thirty-one other companies raised over $100 million in September, namely:
- Groq ($750 million) an artificial intelligence interface technology designed to address the industry’s demands of computing speed, quality, and energy efficiency, enabling companies to improve workloads in artificial intelligence and quality-performance computing.
- Quantinuum ($600 million) a technology company intended for developing, commercializing, and applying quantum computing, enabling industries and researchers to achieve breakthroughs, improve operational capabilities, and stay at the forefront of innovation in their respective fields.
- Capital RX ($400 million) a health technology company that is leading the transformation of the pharmacy benefits industry to ensure patients receive seamless access to medication at the lowest price.
- Filevine ($400 million) a legal case management software designed to offer text-to-case-file, threaded tasks, auto-tagging, and reports, enabling law firms to collaborate on case files with their team and communicate with clients.
- me ($340 million) an identity platform designed to make group affiliation verification secure, enabling military, students, first responders, teachers, and government employees to prove their identity online via a single login and avail discounts on various networks.
- Strive Health ($300 million) a care delivery model designed to improve chronic kidney disease care, enabling healthcare providers to cut inpatient utilization, increase the adoption of home dialysis, and significantly improve patient outcomes and experience.
- Divergent ($290 million) an end-to-end digital production system designed to improve industrial-scale manufacturing processes, enabling vehicle companies to eliminate tooling and drive radical innovation, capital reduction, and sustainability in vehicle manufacturing.
- Modular ($250 million) an artificial intelligence development platform designed to rebuild artificial intelligence infrastructure for everyone, enabling developers with tools that can be easily adopted into existing workflows without re-architecting or rewriting their code.
- Replit ($250 million) a collaborative software development platform designed for creating and deploying applications, enabling developers and teams to optimize coding processes, boost efficiency, and design, evaluate, and implement software entirely online.
- Lila Sciences ($235 million) a scientific superintelligence platform designed to accelerate discovery in life, chemical, and materials sciences, enabling researchers to generate new scientific knowledge across disciplines with greater speed, scale, and accuracy.
- Quera Computing ($230 million) an advanced neutral-atoms-based quantum computer designed to solve existing computational problems, enabling researchers to make scientific discoveries across disciplines like physics, materials science, and chemistry.
- Flying Tulip ($200 million) a decentralized financial infrastructure designed for trading, lending, and structured yield strategies, enabling institutional and retail participants with capital efficiency, risk control, and combined trading, lending, and liquidity services.
- Apex ($200 million) a standardized satellite bus designed to accelerate access to space for commercial and government missions, enabling aerospace companies to deploy payloads efficiently, reduce time to orbit, and expand mission capabilities.
- Treeline Biosciences ($200 million) a transformative precision medicine intended to treat cancer and other serious conditions, enabling medical professionals to cure cancer and other serious conditions.
- AppZen ($180 million) an autonomous and compliance management intended to help finance teams scale with autonomous processing, saving money and reducing risk while boosting growth, enabling clients to reduce spending, comply with the policy, and streamline the process.
- Distyl AI ($175 million) a generative artificial intelligence platform designed for companies to automate parts of their core operations, enabling enterprises to integrate with existing technologies to deliver efficiencies without disruption.
- Baseten ($150 million) a machine learning model designed to provide infrastructure to deploy models performantly, scalably, and cost-effectively, enabling engineers to get the flexibility to write their code when necessary.
- Enveda Biosciences ($150 million) a drug analysis platform designed to capitalize on the chemical diversity and evolutionary significance of natural samples, enabling clients in the healthcare industry to identify and characterize a wide range of molecules produced by living organisms without isolating individual compounds or conducting extensive experimentation.
- Empower Semiconductor ($140 million) a semiconductor intended to design efficient integrated voltage regulators in processors and memory, enabling businesses to redefine the cost, size, and energy efficiency of voltage regulators for applications.
- Harbor Health ($130 million) a healthcare platform intended to provide personalized, patient-centered care through a collaborative approach, enabling patients to access a variety of primary and specialty care services, including chronic disease management, behavioral health, and overall health and wellness.
- Colossal Biosciences ($120 million) a bioscience and genetic engineering company committed to building radical new technologies to advance the field of genomics, enabling environmental organizations to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition.
- Dyna Robotics ($120 million) an advanced robotic manipulation model designed to automate repetitive and stationary tasks, enabling businesses to generalize robots across diverse tasks and environments and optimize operations.
- Speedchain ($111 million) a payments optimization platform designed to build secure ecosystems and provide custom ledger designs, enabling clients to reduce the cost of manual processing, increase revenue, power communication, and capture enterprise data.
- Aven ($110 million) an enterprise IT infrastructure and datacenter services designed to build and support mission-critical technology environments, enabling businesses seeking robust IT infrastructure to establish scalable, secure environments that support reliable operations and growth.
- Quo ($105 million) a business communication platform designed to support official calling and messaging, helping entrepreneurs and professionals speed up their workflow through automation and shortcuts.
- Zerohash ($104 million) a crypto and stablecoin infrastructure platform designed to allow any platform to integrate digital assets natively into its own customer experience, enabling clients to get secure custody of both fiat and digital assets through its wide banking network and encryption and private key storage infrastructure.
- Eve ($103 million) a data extraction platform designed to streamline legal workflows, enabling legal businesses to build customized documents as per their use case to save time and improve efficiency.
- Upscale AI ($100 million) an artificial intelligence networking company designed to optimize, secure, and automate enterprise network infrastructure, enabling organizations to optimize, secure, and automate their network infrastructure.
- Inspiren ($100 million) an automated patient monitoring platform intended to eradicate preventable harm to patients caused by human error, enabling clinicians to improve the care, safety, and satisfaction of the patients.
- Airia ($100 million) a self-learning spatial analytics platform designed for safety facilities and information technology teams to manage resources, enabling teams to maximize capabilities and improve safety response and planning.
- Invisible Technologies ($100 million) a process orchestration platform designed to automate daily office tasks, enabling organizations to enhance efficiency, reduce operational costs, and allocate resources to strategic initiatives.
The hottest sectors for funding during the month were A.I./Machine Learning, Biotech, Financial Software, Healthtech, and Software Development Apps.
Key funding events in each of these sectors for the month are below:
- I./Machine Learning deals included Figure ($1 billion), Groq ($750 million), Modular ($250 million), Lila Sciences ($235 million), Distyl AI ($175 million), Baseten ($150 million), Upscale AI ($100 million), GreenLite ($50 million), MarqVision ($48 million), HappyRobot ($44 million), ProRata AI ($40 million), Ketryx ($39 million), Atolio ($24 million), Circuit + Chisel ($19.2 million), Salt AI ($10 million), Cassidy ($10 million), and Sophont ($9.2 million).
- Biotech deals included Treeline Biosciences ($200 million), Enveda Biosciences ($150 million), Colossal Biosciences ($120 million), Sparrow Pharmaceuticals ($95 million), Avenzo Therapeutics ($60 million), AllRock Bio ($50 million), Conceivable Life Sciences ($50 million), Octave Bioscience ($35.6 million), LPOXY Therapeutics ($28 million), Manas AI ($26 million), Character Biosciences ($17 million), Synthesize Bio ($10 million), FYR Bio ($8 million), and SciTech Development ($5.5 million).
- Financial Software deals included AppZen ($180 million), Tabs ($55 million), Arch ($52 million), PayNearMe ($50 million), Numeral ($35 million), Aleph ($29 million), Rainforest ($29 million), Dispatch ($18 million), Iris Finance ($6.2 million), Moby ($5 million), and PredictAP ($5 million).
- Healthtech deals included Capital RX ($400 million), Strive Health ($300 million), Penguin AI ($25 million), SureCo ($23 million), Hello Patient ($22.5 million), AmplifyMD ($20 million), Goodpath ($18 million), Lovu Health ($8 million), Reveal HealthTech ($7.2 million), Bonsai Health ($7 million), and Meroka ($6 million).
- Software Development Apps deals included Replit ($250 million), CodeRabbit ($60 million), Factory ($50 million), Obot AI ($35 million), Flox ($25 million), Emergent ($23 million), Blacksmith ($10 million), and Dazl ($10 million).
If you’re looking for outside funding to grow your company, please don’t hesitate to call us at (213) 927-3968 or fill out Growthink Capital’s contact form here.